N. G. Papadopoulos (Athens, Greece), P. Holt (West Perth, Australia)
LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation
H. G. Garn, D. T. Tanja, H. R. Renz (Marburg, Germany)
|  |
Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children
P. Holt, L. Subrata, J. Bizzintino, A. Bosco, K. McKenna, J. Goldblatt, P. Sly, I. Laing, P. Lesouef (Perth, Australia)
| |
Exposure of dendritic cells to biomedical nanoparticles down-regulates their capacity for antigen-specific CD4+ T cell stimulation
C. von Garnier, P. J. Gerber, A. Fink, B. Rothen-Rutishauser, K. De Peyer, L. Nicod, T. Geiser (Bern, Lausanne, Switzerland)
| |
A crucial role for lung interstitial macrophages in preventing airway allergy
D. Bedoret, H. Wallemacq, T. Marichal, F. Quesada Calvo, E. Henry, R. Closset, B. Dewals, A. Vanderplasschen, D. Cataldo, M. Moser, P. Lekeux, F. Bureau (Liège, Gosselies, Belgium)
| |
TLR-3 and -7 ligands induce migration of dendritic (DC) cells from the lung
S. Reuter, N. Dehzad, M. Jung, M. Helen, S. Korn, A. Heinz, M. Stassen, R. Buhl, C. Taube (Mainz, Germany)
|  |
RANTES expression induced by Toll-like receptor 3 and 4 ligands on rat airway smooth muscle cells
K. Okayasu, M. Tamaoka, S. Takayama, M. Furuiye, Y. Miyazaki, Y. Ohtani, N. Inase, Y. Yoshizawa (Tokyo, Japan)
| |
Toll-like receptor 3 expression in fatal asthma
D. Ferreira, L. F. F. Silva, A. B. G. Santos, M. C. R. Medeiros, M. Dolhnikoff, T. Mauad (Sao Paulo, Brazil)
| |
Low number of regulatory T cells in bronchial asthma: association with inflammatory cytokines
A. Hamzaoui, H. Abid, J. Ammar, K. Hamzaoui (Tunis, Ariana, Tunisia)
|  |